Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 272-283 , February 2010

Icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats

Received 20 March 2009 ,Revised 25 June 2009 ,Accepted 27 June 2009.

References 

  1. Abbas SY, Nogueira MI, Azmitia EC. Antagonist-induced increase in 5-HT1A-receptor expression in adult rat hippocampus and cortex. Synapse. 2007;61:531–539
  2. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 1999;160:1–12
  3. Bao AM, Meynen G, Swaab DF. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res. Rev. 2008;57:531–553
  4. Behan DP, Maciejewski D, Chalmers D, De Souza EB. Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells. Brain Res. 1995;698:259–264
  5. Bekris S, Antoniou K, Daskas S, Papadopoulou-Daifoti Z. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav. Brain Res. 2005;161:45–59
  6. Bergström A, Jayatissaa MN, Mørk A, Wiborg O. Stress sensitivity and resilience in the chronic mild stress rat model of depression; an in situ hybridization study. Brain Res. 2008;1196:41–52
  7. Blendy JA. The role of CREB in depression and antidepressant treatment. Biol. Psychiatry. 2006;59:1144–1150
  8. Bowman RE, Zrull MC, Luine VN. Chronic restraint stress enhances radial arm maze performance in female rats. Brain Res. 2001;904:279–289
  9. Brady LS, Gold PW, Herkenham M, Lynn AB, Whitfield HJ. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res. 1992;572:117–125
  10. Bruzzone CM, Belcher JD, Schuld NJ, et al. Quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) method for monitoring highly conserved transgene expression during gene therapy. Transl. Res. 2008;152:290–297
  11. Butterweck V, Winterhoff H, Herkenham M. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats. Mol. Psychiatry. 2001;6:547–564
  12. Carlezon WA, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci. 2005;28:436–445
  13. Cubala WJ, Landowski J. Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression. Psychiatr. Pol. 2006;40:415–430
  14. Dagnino-Subiabre A, Zepeda-Carreno R, Diaz-Veliz G, Mora S, Aboitiz F. Chronic stress induces upregulation of brain-derived neurotrophic factor (BDNF) mRNA and integrin alpha5 expression in the rat pineal gland. Brain Res. 2006;1086:27–34
  15. De Cesare D, Fimia GM, Sassone-Corsi P. Signaling routes to CREM and CREB: plasticity in transcriptional activation. Trends Biochem. Sci. 1999;24:281–285
  16. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, et al. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl. Med. Biol. 2007;34:865–877
  17. Ducottet C, Griebel G, Belzung C. Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2003;27:625–631
  18. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch. Gen. Psychiatry. 1997;54:597–606
  19. Dunn AJ, Swiergiel AH. Effects of acute and chronic stressors and CRF in rat and mouse tests for depression. Ann. N. Y. Acad. Sci. 2008;1148:118–126
  20. Egliston K, McMahon C, Austin M. Stress in pregnancy and infant HPA axis function: conceptual and methodological issues relating to the use of salivary cortisol as an outcome measure. Psychoneuroendocrinology. 2007;32:1–13
  21. Grippo AJ, Sullivan NR, Damjanoska KJ, Crane JW, Carrasco GA, Shi J, et al. Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology (Berl.). 2005;179:769–780
  22. Heinrichs SC, Lapsansky J, Lovenberg TW, De Souza EB, Chalmers DT. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regulatory Peptides. 1997;71:15–21
  23. Henningsen K, Andreasen JT, Bouzinova EV, Jayatissa MN, Jensen MS, Redrobe JP, et al. Cognitive deficits in the rat chronic mild stress model for depression: relation to anhedonic-like responses. Behav. Brain Res. 2009;198:136–141
  24. Impey S, McCorkle SR, Cha-Molstad H, Dwyer JM, Yochum GS, Boss JM, et al. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell. 2004;119:1041–1054
  25. Iwasaki-Sekino A, Mano-Otagiri A, Ohata H, Yamauchi N, Shibasaki T. Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology. 2009;34:226–237
  26. Joels M, Verkuyl JM, Van Riel E. Hippocampal and hypothalamic function after chronic stress. Ann. N. Y. Acad. Sci. 2003;1007:367–378
  27. Katz RJ, Roth KA, Carroll BJ. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci. Biobehav. Rev. 1981;5:247–251
  28. Kemp CF, Woods RJ, Lowry PJ. The corticotrophin-releasing factor-binding protein: an act of several parts. Peptides. 1998;19:1119–1128
  29. Kitraki E, Karandrea D, Kittas C. Long-lasting effects of stress on glucocorticoid receptor gene expression in the rat brain. Neuroendocrinology. 1999;69:331–338
  30. Kovacs KJ, Sawchenko PE. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J. Neurosci. 1996;16:262–273
  31. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455:894–902
  32. Lanfumey L, Mongeau R, Cohen-Salmon C, Hamon M. Corticosteroid–serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci. Biobehav. Rev. 2008;32:1174–1184
  33. Leitch MM, Ingram CD, Young AH, McQuade R, Gartside SE. Flattening the corticosterone rhythm attenuates 5-HT1A autoreceptor function in the rat: relevance for depression. Neuropsychopharmacology. 2003;28:119–125
  34. Liebsch G, Landgraf R, Engelmann M, Lorscher P, Holsboer F. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain. J. Psychiatr. Res. 1999;33:153–163
  35. McClennen SJ, Cortright DN, Seasholtz AF. Regulation of pituitary corticotropin-releasing hormone-binding protein messenger ribonucleic acid levels by restraint stress and adrenalectomy. Endocrinology. 1998;139:4435–4441
  36. Mizoguchi K, Ishige A, Aburada M, Tabira T. Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus. Neuroscience. 2003;119:887–897
  37. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch. Gen. Psychiatry. 1988;45:577–579
  38. Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK, et al. Preclinical models: status of basic research in depression. Biol. Psychiatry. 2002;52:503–528
  39. Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 1996;16:2365–2372
  40. Nickel T, Sonntag A, Schill J, Zobel AW, Ackl N, Brunnauer A, et al. Clinical and neurobiological effects of tianeptine and paroxetine in major depression. J. Clin. Psychopharmacol. 2003;23:155–168
  41. Nielsen DM. Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?. Life Sci. 2006;78:909–919
  42. Nikisch G, Mathe AA, Czernik A, Thiele J, Bohner J, Eap CB, et al. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology (Berl.). 2005;181:751–760
  43. Okuhara DY, Beck SG. Corticosteroids alter 5-hydroxytryptamine1A receptor-effector pathway in hippocampal subfield CA3 pyramidal cells. J. Pharmacol. Exp. Ther. 1998;284:1227–1233
  44. Overstreet DH, Griebel G. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression. Eur. J. Pharmacol. 2004;497:49–53
  45. Pan Y, Kong LD, Xia X, Zhang WY, Xia ZH, Jiang FX. Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacol. Biochem. Behav. 2005;82:686–694
  46. Pan Y, Zhang WY, Xia X, Kong LD. Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague–Dawley rats. Biol. Pharm. Bull. 2006;29:2399–2403
  47. Pan Y, Kong LD, Li YC, Xia X, Kung HF, Jiang FX. Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacol. Biochem. Behav. 2007;87:130–140
  48. Paxinos G, Watson C. The Rat Brain, Stereotaxic Coordinates. San Diego: Academic Press; 1998;
  49. Pitchot W, Herrera C, Ansseau M. HPA axis dysfunction in major depression: relationship to 5-HT(1A) receptor activity. Neuropsychobiology. 2001;44:74–77
  50. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry. 2000;57:174–180
  51. Sartorius A, Henn FA. Deep brain stimulation of the lateral habenula in treatment resistant major depression. Med. Hypotheses. 2007;69:1305–1308
  52. Stein EJ, da Silveira Filho NG, Machado DC, Hipólide DC, Barlow K, Nobrega JN. Chronic mild stress induces widespread decreases in thyroid hormone alpha(1) receptor mRNA levels in brain—Reversal by imipramine. Psychoneuroendocrinology. 2009;34:281–286
  53. Stout SC, Owens MJ, Nemeroff CB. Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. J. Pharmacol. Exp. Ther. 2002;300:1085–1092
  54. Tacchi R, Ferrari A, Loche A, Bertolini A. Sucrose intake: increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73. Pharmacol. Res. 2008;57:464–468
  55. Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol. Rev. 2006;58:115–134
  56. Thomson F, Craighead M. Innovative approaches for the treatment of depression: targeting the HPA axis. Neurochem. Res. 2008;33:691–707
  57. Twardowska K, Rybakowski J. Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review. Psychiatr. Pol. 1996;30:741–755
  58. Van Den Eede F, Van Broeckhoven C, Claes SJ. Corticotropin-releasing factor-binding protein, stress and major depression. Ageing Res. Rev. 2005;4:213–239
  59. Wang MQ, Bi ZhM, Li P, Ji H, Cheng FL. Determination of epimedin C and icariin in Herba Epimedii by HPLC. Zhongguo Zhong Yao Za Zhi. 2003;28:1025–1027
  60. Watanabe Y, Sakai RR, McEwen BS, Mendelson S. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res. 1993;615:87–94
  61. Webster MJ, Knable MB, O’Grady J, Orthmann J, Weickert CS. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiatry. 2002;7:985–994
  62. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev. 1992;16:525–534

PII: S0306-4530(09)00210-8

doi: 10.1016/j.psyneuen.2009.06.020

Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 272-283 , February 2010

Article Tools

* Image Usage & Resolution